EPISODE · Dec 30, 2022 · 45 MIN
Omidenepag: A New Category of Topical Glaucoma Therapy
from Experts InSight
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Embed this episode
NOW PLAYING
Omidenepag: A New Category of Topical Glaucoma Therapy
0:00
45:47
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Experts InSight?
This episode is 45 minutes long.
When was this Experts InSight episode published?
This episode was published on December 30, 2022.
Can I download this Experts InSight episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!